ArticleInternational journal of general medicine2026
Fetal Copy Number Variant Detection in Pregnancies with Ultrasound Soft Markers: A Maternal Age-Stratified Retrospective Study.
Article in International journal of general medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Prenatal ultrasound soft markers are common indicators for fetal genetic screening, while the correlation between maternal age and fetal copy number variant (CNV) detection remains controversial. This study aimed to analyze CNV characteristics in fetuses with ultrasound soft marker abnormalities and explore the influence of maternal age on CNV detection. Methods: A total of 468 fetuses with abnormal ultrasound soft markers were enrolled and divided into <35 years (n=390) and ≥35 years (n=78) groups based on maternal age. Chromosomal microarray analysis (CMA) was performed for the enrolled fetuses. Fetal pathogenic/likely pathogenic (P/LP) CNVs and variants of uncertain significance (VUS) were detected and statistically analyzed. Results: The overall detection rates of P/LP CNVs and VUS were 4.1% and 9.0%, respectively. Notably, the P/LP CNVs detection rate was significantly higher in women aged <35 years (4.9%) than in those aged ≥35 years (0%, Conclusion: As a single‑center retrospective study with underpowered subgroup analyses, our findings suggest that younger pregnant women with ultrasonic soft‑marker abnormalities may still carry risk of fetal pathogenic CNVs. CMA should be considered in pregnancies with ultrasonic soft marker abnormalities after individualized counseling, regardless of maternal age.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.